Product Guide

Safety data sheet according to Regulation (EC) No 1907/2006, Annex II
Revision date / version: 17.01.2020 / 0012
Replacing version dated / version: 27.08.2019 / 0011
Valid from: 17.01.2020
PDF print date: 20.01.2020
Power Care Tabs
Surface tension: Not determined
Solvents content: Not determined
SECTION 10: Stability and reactivity
10.1 Reactivity
The product has not been tested.
10.2 Chemical stability
Stable with proper storage and handling.
10.3 Possibility of hazardous reactions
No dangerous reactions are known.
10.4 Conditions to avoid
Heating
10.5 Incompatible materials
Bases
Oxidizing agents
Aluminium
Zinc
Light metals
10.6 Hazardous decomposition products
No decomposition when used as directed.
SECTION 11: Toxicological information
11.1 Information on toxicological effects
Possibly more information on health effects, see Section 2.1 (classification).
Power Care Tabs
Toxicity / effect Endpoint Value Unit Organism Test method Notes
Acute toxicity, by oral route: ATE 1973 mg/kg calculated value
Acute toxicity, by dermal
route:
n.d.a.
Acute toxicity, by inhalation: n.d.a.
Skin corrosion/irritation: n.d.a.
Serious eye
damage/irritation:
n.d.a.
Respiratory or skin
sensitisation:
n.d.a.
Germ cell mutagenicity: n.d.a.
Carcinogenicity: n.d.a.
Reproductive toxicity: n.d.a.
Specific target organ toxicity -
single exposure (STOT-SE):
n.d.a.
Specific target organ toxicity -
repeated exposure (STOT-
RE):
n.d.a.
Aspiration hazard: n.d.a.
Symptoms: n.d.a.
Bronopol (INN)
Toxicity / effect Endpoint Value Unit Organism Test method Notes
Acute toxicity, by oral route: LD50 193-211 mg/kg Rat OECD 401 (Acute
Oral Toxicity)
Acute toxicity, by dermal
route:
LD50 > 2000 mg/kg Rat OECD 402 (Acute
Dermal Toxicity)
Does not
conform with
EU
classification.
Acute toxicity, by inhalation: LC50 >0,588 mg/l/4h Rat Aerosol
Page 9 of 16